{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:44:58Z","timestamp":1793295898386,"version":"4.5.0"},"reference-count":155,"publisher":"Bentham Science Publishers Ltd.","issue":"24","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Cardiovascular diseases (CVDs) are serious life-threatening illnesses and significant\nproblematic issues for public health having a heavy economic burden on all society\nworldwide. The high incidence of these diseases as well as high mortality rates make\nthem the leading causes of death and disability. Therefore, finding novel and more effective\ntherapeutic methods is urgently required. Gallic acid, an herbal medicine with numerous\nbiological properties, has been utilized in the treatment of various diseases for\nthousands of years. It has been demonstrated that gallic acid possesses pharmacological\npotential in regulating several molecular and cellular processes such as apoptosis and autophagy.\nMoreover, gallic acid has been investigated in the treatment of CVDs both in\nvivo and in vitro. Herein, we aimed to review the available evidence on the therapeutic\napplication of gallic acid for CVDs including myocardial ischemia-reperfusion injury\nand infarction, drug-induced cardiotoxicity, hypertension, cardiac fibrosis, and heart failure,\nwith a focus on underlying mechanisms.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673259299230921150030","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T04:20:17Z","timestamp":1696998017000},"page":"3733-3751","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Protective Roles and Therapeutic Effects of Gallic Acid in the\nTreatment of Cardiovascular Diseases: Current Trends and Future\nDirections"],"prefix":"10.2174","volume":"31","author":[{"given":"Zahra","family":"Momeni","sequence":"first","affiliation":[{"name":"Kurdistan University of Medical Sciences, Sanandaj, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Danesh","sequence":"additional","affiliation":[{"name":"Research Hub Institute, Tehran University of\nMedical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Ahmadpour","sequence":"additional","affiliation":[{"name":"Research Hub Institute, Tehran University of\nMedical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Eshraghi","sequence":"additional","affiliation":[{"name":"School of Medicine, Kashan University of Medical Sciences, Kashan,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Farkhondeh","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Pharmacology, School of Pharmacy, Birjand University of Medical\nSciences, Birjand, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Pourhanifeh","sequence":"additional","affiliation":[{"name":"Research Hub Institute, Tehran University of\nMedical Sciences, Tehran, Iran"},{"name":"Student Research Committee, Kashan University of Medical Sciences, Kashan,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Samarghandian","sequence":"additional","affiliation":[{"name":"University of Neyshabur Healthy Ageing Research Centre, Neyshabur University of Medical Sciences, Neyshabur, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"Benjamin E.J.","year":"2019","unstructured":"Benjamin E.J.; Muntner P.; Alonso A.; Bittencourt M.S.; Callaway C.W.; Carson A.P.; Chamberlain A.M.; Chang A.R.; Cheng S.; Das S.R.; Delling F.N.; Djousse L.; Elkind M.S.V.; Ferguson J.F.; Fornage M.; Jordan L.C.; Khan S.S.; Kissela B.M.; Knutson K.L.; Kwan T.W.; Lackland D.T.; Lewis T.T.; Lichtman J.H.; Longenecker C.T.; Loop M.S.; Lutsey P.L.; Martin S.S.; Matsushita K.; Moran A.E.; Mussolino M.E.; O\u2019Flaherty M.; Pandey A.; Perak A.M.; Rosamond W.D.; Roth G.A.; Sampson U.K.A.; Satou G.M.; Schroeder E.B.; Shah S.H.; Spartano N.L.; Stokes A.; Tirschwell D.L.; Tsao C.W.; Turakhia M.P.; VanWagner L.B.; Wilkins J.T.; Wong S.S.; Virani S.S.; Heart disease and stroke statistics\u20142019 update: A report from the American Heart Association. Circulation  2019,139(10),e56-e528","journal-title":"Circulation"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/DMSO.S61438","volume":"7","author":"Lorber D.","year":"2014","unstructured":"Lorber D.; Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes  2014,7,169-183","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"Stone N.J.","year":"2014","unstructured":"Stone N.J.; Robinson J.G.; Lichtenstein A.H.; Bairey Merz C.N.; Blum C.B.; Eckel R.H.; Goldberg A.C.; Gordon D.; Levy D.; Lloyd-Jones D.M.; McBride P.; Schwartz J.S.; Shero S.T.; Smith S.C.; Watson K.; Wilson P.W.F.; 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol  2014,63(25)(25 Pt B),2889-2934","journal-title":"J Am Coll Cardiol"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Samarghandian, S., Borji, A. and Hidar Tabasi, S.,  Effects of Cichorium intybus linn on blood glucose, lipid constituents and selected oxidative stress parameters in streptozotocin-induced diabetic rats. Cardiovasc. Haematol. Disord. Drug Targets (Formerly Current Drug Targets-Cardiovasc. Hematol. Disord.), 2013, 13(3), 231-236.","DOI":"10.2174\/1871529X13666131129103139"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0960-894X(01)00724-7","volume":"12","author":"Zhang H.Y.","year":"2002","unstructured":"Zhang H.Y.; Wang L.F.; Theoretical elucidation on structure\u2013Antioxidant activity relationships for indolinonic hydroxylamines. Bioorg Med Chem Lett  2002,12(2),225-227","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2009.05.003","volume":"615","author":"Stanely Mainzen Prince P.","year":"2009","unstructured":"Stanely Mainzen Prince P.; Priscilla H.; Devika P.T.; Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats. Eur J Pharmacol  2009,615(1-3),139-143","journal-title":"Eur J Pharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2006.10.003","volume":"165","author":"Abdelwahed A.","year":"2007","unstructured":"Abdelwahed A.; Bouhlel I.; Skandrani I.; Valenti K.; Kadri M.; Guiraud P.; Steiman R.; Mariotte A.M.; Ghedira K.; Laporte F.; Dijoux-Franca M.G.; Chekir-Ghedira L.; Study of antimutagenic and antioxidant activities of Gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia lentiscus. Chem Biol Interact  2007,165(1),1-13","journal-title":"Chem Biol Interact"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0308-8146(02)00145-0","volume":"79","author":"Yen G.C.","year":"2002","unstructured":"Yen G.C.; Duh P.D.; Tsai H.L.; Antioxidant and pro-oxidant properties of ascorbic acid and gallic acid. Food Chem  2002,79(3),307-313","journal-title":"Food Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.freeradbiomed.2010.04.013","volume":"49","author":"Pal C.","year":"2010","unstructured":"Pal C.; Bindu S.; Dey S.; Alam A.; Goyal M.; Iqbal M.S.; Maity P.; Adhikari S.S.; Bandyopadhyay U.; Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis. Free Radic Biol Med  2010,49(2),258-267","journal-title":"Free Radic Biol Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1248\/bpb.31.149","volume":"31","author":"Ban J.Y.","year":"2008","unstructured":"Ban J.Y.; Nguyen H.T.T.; Lee H.J.; Cho S.O.; Ju H.S.; Kim J.Y.; Bae K.; Song K.S.; Seong Y.H.; Neuroprotective properties of gallic acid from Sanguisorbae radix on amyloid \u03b2 protein (25--35)-induced toxicity in cultured rat cortical neurons. Biol Pharm Bull  2008,31(1),149-153","journal-title":"Biol Pharm Bull"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"110985","DOI":"10.1016\/j.biopha.2020.110985","volume":"133","author":"Bai J.","year":"2021","unstructured":"Bai J.; Zhang Y.; Tang C.; Hou Y.; Ai X.; Chen X.; Zhang Y.; Wang X.; Meng X.; Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases. Biomed Pharmacother  2021,133,110985","journal-title":"Biomed Pharmacother"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00128-012-0645-4","volume":"89","author":"Nabavi S.F.","year":"2012","unstructured":"Nabavi S.F.; Habtemariam S.; Jafari M.; Sureda A.; Nabavi S.M.; Protective role of gallic acid on sodium fluoride induced oxidative stress in rat brain. Bull Environ Contam Toxicol  2012,89(1),73-77","journal-title":"Bull Environ Contam Toxicol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.tiv.2011.12.018","volume":"26","author":"Chandramohan Reddy T.","year":"2012","unstructured":"Chandramohan Reddy T.; Bharat Reddy D.; Aparna A.; Arunasree K.M.; Gupta G.; Achari C.; Reddy G.V.; Lakshmipathi V.; Subramanyam A.; Reddanna P.; Anti-leukemic effects of gallic acid on human leukemia K562 cells: Downregulation of COX-2, inhibition of BCR\/ABL kinase and NF-\u03baB inactivation. Toxicol In Vitro  2012,26(3),396-405","journal-title":"Toxicol In Vitro"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/mnfr.201200167","volume":"56","author":"Chen Y.J.","year":"2012","unstructured":"Chen Y.J.; Chang L.S.; Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr\/Abl. Mol Nutr Food Res  2012,56(9),1398-1412","journal-title":"Mol Nutr Food Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.taap.2012.10.019","volume":"266","author":"Ho H.H.","year":"2013","unstructured":"Ho H.H.; Chang C.S.; Ho W.C.; Liao S.Y.; Lin W.L.; Wang C.J.; Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT\/small GTPase signals and inhibition of NF-\u03baB activity. Toxicol Appl Pharmacol  2013,266(1),76-85","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.foodchem.2012.08.009","volume":"136","author":"Hsiang C.Y.","year":"2013","unstructured":"Hsiang C.Y.; Hseu Y.C.; Chang Y.C.; Kumar K.J.S.; Ho T.Y.; Yang H.L.; Toona sinensis and its major bioactive compound gallic acid inhibit LPS-induced inflammation in nuclear factor-\u03baB transgenic mice as evaluated by in vivo bioluminescence imaging. Food Chem  2013,136(2),426-434","journal-title":"Food Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jbspin.2012.08.010","volume":"80","author":"Yoon C.H.","year":"2013","unstructured":"Yoon C.H.; Chung S.J.; Lee S.W.; Park Y.B.; Lee S.K.; Park M.C.; Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes. Joint Bone Spine  2013,80(3),274-279","journal-title":"Joint Bone Spine"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cbi.2008.12.012","volume":"179","author":"Priscilla D.H.","year":"2009","unstructured":"Priscilla D.H.; Prince P.S.M.; Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. Chem Biol Interact  2009,179(2-3),118-124","journal-title":"Chem Biol Interact"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s12012-012-9170-2","volume":"12","author":"Umadevi S.","year":"2012","unstructured":"Umadevi S.; Gopi V.; Simna S.P.; Parthasarathy A.; Yousuf S.M.J.; Elangovan V.; Studies on the cardioprotective role of gallic acid against AGE-induced cell proliferation and oxidative stress in H9C2 (2-1) cells. Cardiovasc Toxicol  2012,12(4),304-311","journal-title":"Cardiovasc Toxicol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jbt.20360","volume":"25","author":"Punithavathi V.R.","year":"2011","unstructured":"Punithavathi V.R.; Stanely Mainzen Prince P.; Kumar M.R.; Selvakumari C.J.; Protective effects of gallic acid on hepatic lipid peroxide metabolism, glycoprotein components and lipids in streptozotocin-induced type II diabetic wistar rats. J Biochem Mol Toxicol  2011,25(2),68-76","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.fct.2009.03.021","volume":"47","author":"Tung Y.T.","year":"2009","unstructured":"Tung Y.T.; Wu J.H.; Huang C.C.; Peng H.C.; Chen Y.L.; Yang S.C.; Chang S.T.; Protective effect of Acacia confusa bark extract and its active compound gallic acid against carbon tetrachloride-induced chronic liver injury in rats. Food Chem Toxicol  2009,47(6),1385-1392","journal-title":"Food Chem Toxicol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1590\/S0074-02762008000500005","volume":"103","author":"Kratz J.M.","year":"2008","unstructured":"Kratz J.M.; Andrighetti-Fr\u00f6hner C.R.; Kolling D.J.; Leal P.C.; Cirne-Santos C.C.; Yunes R.A.; Nunes R.J.; Trybala E.; Bergstr\u00f6m T.; Frugulhetti I.C.P.P.; Barardi C.R.M.; Sim\u00f5es C.M.O.; Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Mem Inst Oswaldo Cruz  2008,103(5),437-442","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1248\/bpb.b13-00225","volume":"36","author":"Jung J.","year":"2013","unstructured":"Jung J.; Bae K.H.; Jeong C.S.; Anti-Helicobacter pylori and antiulcerogenic activities of the root cortex of Paeonia suffruticosa. Biol Pharm Bull  2013,36(10),1535-1539","journal-title":"Biol Pharm Bull"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0968-0896(02)00436-4","volume":"11","author":"Kubo I.","year":"2003","unstructured":"Kubo I.; Fujita K.; Nihei K.; Masuoka N.; Non-antibiotic antibacterial activity of dodecyl gallate. Bioorg Med Chem  2003,11(4),573-580","journal-title":"Bioorg Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0960-894X(00)00656-9","volume":"11","author":"Kubo I.","year":"2001","unstructured":"Kubo I.; Xiao P.; Fujita K.; Antifungal activity of octyl gallate: Structural criteria and mode of action. Bioorg Med Chem Lett  2001,11(3),347-350","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1210\/en.2014-1354","volume":"156","author":"Doan K.V.","year":"2015","unstructured":"Doan K.V.; Ko C.M.; Kinyua A.W.; Yang D.J.; Choi Y.H.; Oh I.Y.; Nguyen N.M.; Ko A.; Choi J.W.; Jeong Y.; Jung M.H.; Cho W.G.; Xu S.; Park K.S.; Park W.J.; Choi S.Y.; Kim H.S.; Moh S.H.; Kim K.W.; Gallic acid regulates body weight and glucose homeostasis through AMPK activation. Endocrinology  2015,156(1),157-168","journal-title":"Endocrinology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nutres.2015.10.001","volume":"36","author":"Huang D.W.","year":"2016","unstructured":"Huang D.W.; Chang W.C.; Wu J.S.B.; Shih R.W.; Shen S.C.; Gallic acid ameliorates hyperglycemia and improves hepatic carbohydrate metabolism in rats fed a high-fructose diet. Nutr Res  2016,36(2),150-160","journal-title":"Nutr Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0278-6915(01)00054-0","volume":"39","author":"Niho N.","year":"2001","unstructured":"Niho N.; Shibutani M.; Tamura T.; Toyoda K.; Uneyama C.; Takahashi N.; Hirose M.; Subchronic toxicity study of gallic acid by oral administration in F344 rats. Food Chem Toxicol  2001,39(11),1063-1070","journal-title":"Food Chem Toxicol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"20443","DOI":"10.3390\/ijms141020443","volume":"14","author":"Su T.R.","year":"2013","unstructured":"Su T.R.; Lin J.J.; Tsai C.C.; Huang T.K.; Yang Z.Y.; Wu M.O.; Zheng Y.Q.; Su C.C.; Wu Y.J.; Inhibition of melanogenesis by gallic acid: Possible involvement of the PI3K\/Akt, MEK\/ERK and Wnt\/\u03b2-catenin signaling pathways in B16F10 cells. Int J Mol Sci  2013,14(10),20443-20458","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","unstructured":"Shaterzadeh-Yazdi H, Noorbakhsh MF, Hayati F, Samarghandian S, Farkhondeh T. Immunomodulatory and anti-inflammatory effects of thymoquinone. Cardiovasc. Haematol. Disord. Drug Targets (Formerly Current Drug Targets-Cardiovascular and Hematological Disorders). 2018, 18(1), 52-60.","DOI":"10.1155\/2018\/1081287"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3390\/nu12051479","volume":"12","author":"Tanaka M.","year":"2020","unstructured":"Tanaka M.; Sato A.; Kishimoto Y.; Mabashi-Asazuma H.; Kondo K.; Iida K.; Gallic acid inhibits lipid accumulation via ampk pathway and suppresses apoptosis and macrophage-mediated inflammation in hepatocytes. Nutrients  2020,12(5),1479","journal-title":"Nutrients"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.tiv.2015.10.005","volume":"30","author":"Haute G.V.","year":"2015","unstructured":"Haute G.V.; Caberlon E.; Squizani E.; de Mesquita F.C.; Pedrazza L.; Martha B.A.; da Silva Melo D.A.; Cassel E.; Czepielewski R.S.; Bitencourt S.; Goettert M.I.; de Oliveira J.R.; Gallic acid reduces the effect of LPS on apoptosis and inhibits the formation of neutrophil extracellular traps. Toxicol In Vitro  2015,30(1),309-317","journal-title":"Toxicol In Vitro"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/mnfr.201100262","volume":"55","author":"Kim M.J.","year":"2011","unstructured":"Kim M.J.; Seong A.R.; Yoo J.Y.; Jin C.H.; Lee Y.H.; Kim Y.J.; Lee J.; Jun W.J.; Yoon H.G.; Gallic acid, a histone acetyltransferase inhibitor, suppresses \u03b2-amyloid neurotoxicity by inhibiting microglial-mediated neuroinflammation. Mol Nutr Food Res  2011,55(12),1798-1808","journal-title":"Mol Nutr Food Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9585727","volume":"2019","author":"Li Y.","year":"2019","unstructured":"Li Y.; Yang Q.; Shi Z.; Zhou M.; Yan L.; Li H.; Xie Y.; Wang S.; The anti-inflammatory effect of feiyangchangweiyan capsule and its main components on pelvic inflammatory disease in rats via the regulation of the NF- \u03ba B and BAX\/BCL-2 pathway. Evid Based Complement Alternat Med  2019,2019,1-11","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yrtph.2018.11.010","volume":"101","author":"Variya B.C.","year":"2019","unstructured":"Variya B.C.; Bakrania A.K.; Madan P.; Patel S.S.; Acute and 28-days repeated dose sub-acute toxicity study of gallic acid in albino mice. Regul Toxicol Pharmacol  2019,101,71-78","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.2147\/IJN.S369373","volume":"17","author":"Shamsi S.","year":"2022","unstructured":"Shamsi S.; Abdul Ghafor A.A.H.; Norjoshukrudin N.H.; Ng I.M.J.; Abdullah S.N.S.; Sarchio S.N.E.; Md Yasin F.; Abd Gani S.; Mohd Desa M.N.; Stability, toxicity, and antibacterial potential of gallic acid-loaded graphene oxide (gago) against methicillin-resistant Staphylococcus aureus (MRSA) strains. Int J Nanomedicine  2022,17,5781-5807","journal-title":"Int J Nanomedicine"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.mrfmmm.2007.10.005","volume":"638","author":"Kim J.H.","year":"2008","unstructured":"Kim J.H.; Kang N.J.; Lee B.K.; Lee K.W.; Lee H.J.; Gallic acid, a metabolite of the antioxidant propyl gallate, inhibits gap junctional intercellular communication via phosphorylation of connexin 43 and extracellular-signal-regulated kinase1\/2 in rat liver epithelial cells. Mutat Res  2008,638(1-2),175-183","journal-title":"Mutat Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/app9030533","volume":"9","author":"Quiles-Carrillo L.","year":"2019","unstructured":"Quiles-Carrillo L.; Montanes N.; Lagaron J.; Balart R.; Torres-Giner S.; Bioactive multilayer polylactide films with controlled release capacity of gallic acid accomplished by incorporating electrospun nanostructured coatings and interlayers. Appl Sci  2019,9(3),533","journal-title":"Appl Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/polym12010031","volume":"12","author":"Quiles-Carrillo L.","year":"2019","unstructured":"Quiles-Carrillo L.; Montava-Jord\u00e0 S.; Boronat T.; Sammon C.; Balart R.; Torres-Giner S.; On the use of gallic acid as a potential natural antioxidant and ultraviolet light stabilizer in cast-extruded bio-based high-density polyethylene films. Polymers  2019,12(1),31","journal-title":"Polymers"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3389\/fphar.2018.01486","volume":"9","author":"Rajamanickam K.","year":"2019","unstructured":"Rajamanickam K.; Yang J.; Sakharkar M.K.; Gallic acid potentiates the antimicrobial activity of tulathromycin against two key bovine respiratory disease (BRD) causing-pathogens. Front Pharmacol  2019,9,1486","journal-title":"Front Pharmacol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/v8060157","volume":"8","author":"Lee J.H.","year":"2016","unstructured":"Lee J.H.; Oh M.; Seok J.; Kim S.; Lee D.; Bae G.; Bae H.I.; Bae S.; Hong Y.M.; Kwon S.O.; Lee D.H.; Song C.S.; Mun J.; Chung M.; Kim K.; Antiviral effects of black raspberry (Rubus coreanus) seed and its gallic acid against influenza virus infection. Viruses  2016,8(6),157","journal-title":"Viruses"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-019-00671-9","volume":"28","author":"Harikrishnan H.","year":"2020","unstructured":"Harikrishnan H.; Jantan I.; Alagan A.; Haque M.A.; Modulation of cell signaling pathways by Phyllanthus amarus and its major constituents: Potential role in the prevention and treatment of inflammation and cancer. Inflammopharmacology  2020,28(1),1-18","journal-title":"Inflammopharmacology"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12906-017-1555-0","volume":"17","author":"BenSaad L.A.","year":"2017","unstructured":"BenSaad L.A.; Kim K.H.; Quah C.C.; Kim W.R.; Shahimi M.; Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin AandB isolated from Punica granatum. BMC Complement Altern Med  2017,17(1),47","journal-title":"BMC Complement Altern Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.3389\/fimmu.2018.02281","volume":"9","author":"Baptista B.J.A.","year":"2018","unstructured":"Baptista B.J.A.; Granato A.; Canto F.B.; Montalv\u00e3o F.; Tostes L.; de Matos Guedes H.L.; Coutinho A.; Bellio M.; Vale A.M.; Nobrega A.; TLR9 signaling suppresses the canonical plasma cell differentiation program in follicular B cells. Front Immunol  2018,9,2281","journal-title":"Front Immunol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1111\/bph.14703","volume":"176","author":"Parada E.","year":"2019","unstructured":"Parada E.; Casas A.I.; Palomino-Antolin A.; G\u00f3mez-Rangel V.; Rubio-Navarro A.; Farr\u00e9-Alins V.; Narros-Fernandez P.; Guerrero-Hue M.; Moreno J.A.; Rosa J.M.; Roda J.M.; Hern\u00e1ndez-Garc\u00eda B.J.; Egea J.; Early toll-like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro-inflammatory phenotype in rodent and human brain ischaemia models. Br J Pharmacol  2019,176(15),2764-2779","journal-title":"Br J Pharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/cbf.2874","volume":"31","author":"Kartkaya K.","year":"2013","unstructured":"Kartkaya K.; O\u011flak\u00e7\u0131 A.; \u015eent\u00fcrk H.; Bayramo\u011flu G.; Canbek M.; Kanbak G.; Investigation of the possible protective role of gallic acid on paraoxanase and arylesterase activities in livers of rats with acute alcohol intoxication. Cell Biochem Funct  2013,31(3),208-213","journal-title":"Cell Biochem Funct"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1615\/CritRevEukaryotGeneExpr.2019025602","volume":"29","author":"Suganya S.","year":"2019","unstructured":"Suganya S.; Schneider L.; Nandagopal B.; Molecular docking studies of potential inhibition of the alcohol dehydrogenase enzyme by phyllanthin, hypophyllanthin and gallic acid. Crit Rev Eukaryot Gene Expr  2019,29(4),287-294","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"ref=48","first-page":"100","volume":"1","author":"Goel R.","year":"2012","unstructured":"Goel R.; Medicinal plants as antidiabetics: A review. Int Bull Drug Res  2012,1(2),100-107","journal-title":"Int Bull Drug Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S2222-1808(12)60054-1","volume":"2","author":"Patel D.K.","year":"2012","unstructured":"Patel D.K.; Kumar R.; Laloo D.; Hemalatha S.; Natural medicines from plant source used for therapy of diabetes mellitus: An overview of its pharmacological aspects. Asian Pac J Trop Dis  2012,2(3),239-250","journal-title":"Asian Pac J Trop Dis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0378-8741(02)00217-9","volume":"83","author":"Sabu M.C.","year":"2002","unstructured":"Sabu M.C.; Smitha K.; Kuttan R.; Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol  2002,83(1-2),109-116","journal-title":"J Ethnopharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/0974-8490.89743","volume":"3","author":"Goyal R.K.","year":"2011","unstructured":"Goyal R.K.; Patel S.S.; Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacognosy Res  2011,3(4),239-245","journal-title":"Pharmacognosy Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/jmf.2005.8.362","volume":"8","author":"Rao T.P.","year":"2005","unstructured":"Rao T.P.; Sakaguchi N.; Juneja L.R.; Wada E.; Yokozawa T.; Amla (Emblica officinalis Gaertn.) extracts reduce oxidative stress in streptozotocin-induced diabetic rats. J Med Food  2005,8(3),362-368","journal-title":"J Med Food"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"152906","DOI":"10.1016\/j.phymed.2019.152906","volume":"73","author":"Variya B.C.","year":"2020","unstructured":"Variya B.C.; Bakrania A.K.; Patel S.S.; Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-\u03b3 and Akt signaling. Phytomedicine  2020,73,152906","journal-title":"Phytomedicine"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/1920-4159.1000213","volume":"8","author":"Nayeem N.","year":"2016","unstructured":"Nayeem N.; Smb A.; Gallic acid: A promising lead molecule for drug development. J Appl Pharm  2016,8(2),1-4","journal-title":"J Appl Pharm"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"27540","DOI":"10.1039\/C5RA01911G","volume":"5","author":"Badhani B.","year":"2015","unstructured":"Badhani B.; Sharma N.; Kakkar R.; Gallic acid: A versatile antioxidant with promising therapeutic and industrial applications. RSC Adv  2015,5(35),27540-27557","journal-title":"RSC Adv"},{"key":"ref=56","doi-asserted-by":"crossref","unstructured":"Ashrafizadeh M, Ahmadi Z, Kotla NG, Afshar EG, Samarghandian S, Mandegary A, Pardakhty A, Mohammadinejad R, Sethi G. Nanoparticles targeting STATs in cancer therapy. Cells.  2019,  8(10):1158.","DOI":"10.3390\/cells8101158"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s11095-009-9926-y","volume":"26","author":"Kaur M.","year":"2009","unstructured":"Kaur M.; Velmurugan B.; Rajamanickam S.; Agarwal R.; Agarwal C.; Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice. Pharm Res  2009,26(9),2133-2140","journal-title":"Pharm Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/jbt.21575","volume":"28","author":"Wang K.","year":"2014","unstructured":"Wang K.; Zhu X.; Zhang K.; Zhu L.; Zhou F.; Investigation of gallic acid induced anticancer effect in human breast carcinoma MCF-7 cells. J Biochem Mol Toxicol  2014,28(9),387-393","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejphar.2010.05.043","volume":"641","author":"Lu Y.","year":"2010","unstructured":"Lu Y.; Jiang F.; Jiang H.; Wu K.; Zheng X.; Cai Y.; Katakowski M.; Chopp M.; To S.S.T.; Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. Eur J Pharmacol  2010,641(2-3),102-107","journal-title":"Eur J Pharmacol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000337103","volume":"58","author":"Liu Z.","year":"2012","unstructured":"Liu Z.; Li D.; Yu L.; Niu F.; Gallic acid as a cancer-selective agent induces apoptosis in pancreatic cancer cells. Chemotherapy  2012,58(3),185-194","journal-title":"Chemotherapy"},{"key":"ref=61","first-page":"247","volume":"4","author":"Tiejing L.","year":"2010","unstructured":"Tiejing L.; Xin Z.; Xinhuai Z.; Powerful protective effects of gallic acid and tea polyphenols on human hepatocytes injury induced by hydrogen peroxide or carbon tetrachloride in vitro. J Med Plants Res  2010,4(3),247-254","journal-title":"J Med Plants Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.etap.2013.02.011","volume":"35","author":"Verma S.","year":"2013","unstructured":"Verma S.; Singh A.; Mishra A.; Gallic acid: Molecular rival of cancer. Environ Toxicol Pharmacol  2013,35(3),473-485","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.vph.2014.08.005","volume":"63","author":"Kee H.J.","year":"2014","unstructured":"Kee H.J.; Cho S.N.; Kim G.R.; Choi S.Y.; Ryu Y.; Kim I.K.; Hong Y.J.; Park H.W.; Ahn Y.; Cho J.G.; Park J.C.; Jeong M.H.; Gallic acid inhibits vascular calcification through the blockade of BMP2\u2013Smad1\/5\/8 signaling pathway. Vascul Pharmacol  2014,63(2),71-78","journal-title":"Vascul Pharmacol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1800807","DOI":"10.1002\/mnfr.201800807","volume":"63","author":"Yan X.","year":"2019","unstructured":"Yan X.; Zhang Y.L.; Zhang L.; Zou L.X.; Chen C.; Liu Y.; Xia Y.L.; Li H.H.; Gallic acid suppresses cardiac hypertrophic remodeling and heart failure. Mol Nutr Food Res  2019,63(5),1800807","journal-title":"Mol Nutr Food Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1700482","DOI":"10.1002\/mnfr.201700482","volume":"62","author":"Ferk F.","year":"2018","unstructured":"Ferk F.; Kundi M.; Brath H.; Szekeres T.; Al-Serori H.; Mi\u0161\u00edk M.; Saiko P.; Marculescu R.; Wagner K.H.; Knasmueller S.; Gallic acid improves health-associated biochemical parameters and prevents oxidative damage of DNA in Type 2 diabetes patients: Results of a placebo-controlled pilot study. Mol Nutr Food Res  2018,62(4),1700482","journal-title":"Mol Nutr Food Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/1874192401004010302","volume":"4","author":"Sandoo A.","year":"2010","unstructured":"Sandoo A.; Veldhuijzen van Zanten J.J.C.S.; Metsios G.S.; Carroll D.; Kitas G.D.; The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J  2010,4(1),302-312","journal-title":"Open Cardiovasc Med J"},{"key":"ref=67","first-page":"109","volume":"11","author":"Bakheet M.S.","year":"2014","unstructured":"Bakheet M.S.; Antioxidants (vitamin E and gallic acid) as valuable protective factors against myocardial infarction. Basic Res J Med Clin Sci  2014,11,109-122","journal-title":"Basic Res J Med Clin Sci"},{"key":"ref=68","first-page":"11","volume":"10","author":"Akbari G.","year":"2020","unstructured":"Akbari G.; Molecular mechanisms underlying gallic acid effects against cardiovascular diseases: An update review. Avicenna J Phytomed  2020,10(1),11-23","journal-title":"Avicenna J Phytomed"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1021\/tx800019a","volume":"21","author":"He X.","year":"2008","unstructured":"He X.; Chen M.G.; Ma Q.; Activation of Nrf2 in defense against cadmium-induced oxidative stress. Chem Res Toxicol  2008,21(7),1375-1383","journal-title":"Chem Res Toxicol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/320454a0","volume":"320","author":"Gryglewski R.J.","year":"1986","unstructured":"Gryglewski R.J.; Palmer R.M.J.; Moncada S.; Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature  1986,320(6061),454-456","journal-title":"Nature"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1161\/ATVBAHA.107.153080","volume":"27","author":"Schrader L.I.","year":"2007","unstructured":"Schrader L.I.; Kinzenbaw D.A.; Johnson A.W.; Faraci F.M.; Didion S.P.; IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler Thromb Vasc Biol  2007,27(12),2576-2581","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bph.14522","volume":"176","author":"Garcia V.","year":"2019","unstructured":"Garcia V.; Sessa W.C.; Endothelial NOS: Perspective and recent developments. Br J Pharmacol  2019,176(2),189-196","journal-title":"Br J Pharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijcard.2013.12.020","volume":"171","author":"Kam A.","year":"2014","unstructured":"Kam A.; Li K.M.; Razmovski-Naumovski V.; Nammi S.; Chan K.; Li G.Q.; Gallic acid protects against endothelial injury by restoring the depletion of DNA methyltransferase 1 and inhibiting proteasome activities. Int J Cardiol  2014,171(2),231-242","journal-title":"Int J Cardiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3389\/fphar.2020.01121","volume":"11","author":"Yan X.","year":"2020","unstructured":"Yan X.; Zhang Q.Y.; Zhang Y.L.; Han X.; Guo S.B.; Li H.H.; Gallic acid attenuates angiotensin ii-induced hypertension and vascular dysfunction by inhibiting the degradation of endothelial nitric oxide synthase. Front Pharmacol  2020,11,1121","journal-title":"Front Pharmacol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"15607","DOI":"10.1038\/s41598-017-15925-1","volume":"7","author":"Jin L.","year":"2017","unstructured":"Jin L.; Piao Z.H.; Sun S.; Liu B.; Kim G.R.; Seok Y.M.; Lin M.Q.; Ryu Y.; Choi S.Y.; Kee H.J.; Jeong M.H.; Gallic acid reduces blood pressure and attenuates oxidative stress and cardiac hypertrophy in spontaneously hypertensive rats. Sci Rep  2017,7(1),15607","journal-title":"Sci Rep"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.3390\/ijms21103508","volume":"21","author":"Goossens E.A.C.","year":"2020","unstructured":"Goossens E.A.C.; de Vries M.R.; Jukema J.W.; Quax P.H.A.; Nossent A.Y.; Myostatin inhibits vascular smooth muscle cell proliferation and local 14q32 microrna expression, but not systemic inflammation or restenosis. Int J Mol Sci  2020,21(10),3508","journal-title":"Int J Mol Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/cvr\/cvn120","volume":"79","author":"Kleemann R.","year":"2008","unstructured":"Kleemann R.; Zadelaar S.; Kooistra T.; Cytokines and atherosclerosis: A comprehensive review of studies in mice. Cardiovasc Res  2008,79(3),360-376","journal-title":"Cardiovasc Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"Libby P.","year":"2011","unstructured":"Libby P.; Ridker P.M.; Hansson G.K.; Progress and challenges in translating the biology of atherosclerosis. Nature  2011,473(7347),317-325","journal-title":"Nature"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","volume":"26","author":"Ramji D.P.","year":"2015","unstructured":"Ramji D.P.; Davies T.S.; Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev  2015,26(6),673-685","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"e0197210","DOI":"10.1371\/journal.pone.0197210","volume":"13","author":"Garc\u00eda-Miguel M.","year":"2018","unstructured":"Garc\u00eda-Miguel M.; Riquelme J.A.; Norambuena-Soto I.; Morales P.E.; Sanhueza-Olivares F.; Nu\u00f1ez-Soto C.; Mondaca-Ruff D.; Cancino-Arenas N.; San Mart\u00edn A.; Chiong M.; Autophagy mediates tumor necrosis factor-\u03b1-induced phenotype switching in vascular smooth muscle A7r5 cell line. PLoS One  2018,13(5),e0197210","journal-title":"PLoS One"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","volume":"136","author":"Carthew R.W.","year":"2009","unstructured":"Carthew R.W.; Sontheimer E.J.; Origins and mechanisms of miRNAs and siRNAs. Cell  2009,136(4),642-655","journal-title":"Cell"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.hlc.2014.01.001","volume":"23","author":"Sayed A.S.M.","year":"2014","unstructured":"Sayed A.S.M.; Xia K.; Salma U.; Yang T.; Peng J.; Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases. Heart Lung Circ  2014,23(6),503-510","journal-title":"Heart Lung Circ"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"L861","DOI":"10.1152\/ajplung.00201.2010","volume":"299","author":"Sarkar J.","year":"2010","unstructured":"Sarkar J.; Gou D.; Turaka P.; Viktorova E.; Ramchandran R.; Raj J.U.; MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol  2010,299(6),L861-L871","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.vph.2018.11.006","volume":"112","author":"Vacante F.","year":"2019","unstructured":"Vacante F.; Denby L.; Sluimer J.C.; Baker A.H.; The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease. Vascul Pharmacol  2019,112,24-30","journal-title":"Vascul Pharmacol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00418-020-01847-z","volume":"153","author":"Zhang M.","year":"2020","unstructured":"Zhang M.; Li F.; Wang X.; Gong J.; Xian Y.; Wang G.; Zheng Z.; Shang C.; Wang B.; He Y.; Wang W.; Lin R.; MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K\/Akt\/mTOR pathway. Histochem Cell Biol  2020,153(5),357-366","journal-title":"Histochem Cell Biol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1111\/jcmm.15316","volume":"24","author":"Wang W.","year":"2020","unstructured":"Wang W.; Chen L.; Shang C.; Jin Z.; Yao F.; Bai L.; Wang R.; Zhao S.; Liu E.; miR-145 inhibits the proliferation and migration of vascular smooth muscle cells by regulating autophagy. J Cell Mol Med  2020,24(12),6658-6669","journal-title":"J Cell Mol Med"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"515","DOI":"10.18632\/aging.100569","volume":"5","author":"Shafique E.","year":"2013","unstructured":"Shafique E.; Choy W.C.; Liu Y.; Feng J.; Cordeiro B.; Lyra A.; Arafah M.; Yassin-Kassab A.; Zanetti A.V.D.; Clements R.T.; Bianchi C.; Benjamin L.E.; Sellke F.W.; Abid M.R.; Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK. Aging  2013,5(7),515-530","journal-title":"Aging"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.2174\/09298673113209990175","volume":"20","author":"Ou T.T.","year":"2013","unstructured":"Ou T.T.; Lin M.C.; Wu C.H.; Lin W.L.; Wang C.J.; Gallic acid attenuates oleic acid-induced proliferation of vascular smooth muscle cell through regulation of AMPK-eNOS-FAS signaling. Curr Med Chem  2013,20(31),3944-3953","journal-title":"Curr Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"8602","DOI":"10.1039\/D0FO02135K","volume":"11","author":"Chung D.J.","year":"2020","unstructured":"Chung D.J.; Wu Y.L.; Yang M.Y.; Chan K.C.; Lee H.J.; Wang C.J.; Nelumbo nucifera leaf polyphenol extract and gallic acid inhibit TNF-\u03b1-induced vascular smooth muscle cell proliferation and migration involving the regulation of miR-21, miR-143 and miR-145. Food Funct  2020,11(10),8602-8611","journal-title":"Food Funct"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2917387","volume":"2018","author":"Sun Q.","year":"2018","unstructured":"Sun Q.; Xin F.; Wen X.; Lu C.; Chen R.; Ruan G.; Protective effects of different kinds of filtered water on hypertensive mouse by suppressing oxidative stress and inflammation. Oxid Med Cell Longev  2018,2018,1-8","journal-title":"Oxid Med Cell Longev"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"210","DOI":"10.11604\/pamj.2019.33.210.18407","volume":"33","author":"Ondimu D.O.","year":"2019","unstructured":"Ondimu D.O.; Kikuvi G.M.; Otieno W.N.; Risk factors for hypertension among young adults (18-35) years attending in Tenwek Mission Hospital, Bomet County, Kenya in 2018. Pan Afr Med J  2019,33,210","journal-title":"Pan Afr Med J"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/406960","volume":"2014","author":"Dinh Q.N.","year":"2014","unstructured":"Dinh Q.N.; Drummond G.R.; Sobey C.G.; Chrissobolis S.; Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. BioMed Res Int  2014,2014,1-11","journal-title":"BioMed Res Int"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"310","author":"Chow C.K.","year":"2013","unstructured":"Chow C.K.; Teo K.K.; Rangarajan S.; Islam S.; Gupta R.; Avezum A.; Bahonar A.; Chifamba J.; Dagenais G.; Diaz R.; Kazmi K.; Lanas F.; Wei L.; Lopez-Jaramillo P.; Fanghong L.; Ismail N.H.; Puoane T.; Rosengren A.; Szuba A.; Temizhan A.; Wielgosz A.; Yusuf R.; Yusufali A.; McKee M.; Liu L.; Mony P.; Yusuf S.; Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA  2013,310(9),959-968","journal-title":"JAMA"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"e19047","DOI":"10.1097\/MD.0000000000019047","volume":"99","author":"Xu R.","year":"2020","unstructured":"Xu R.; Yang K.; Ding J.; Chen G.; Effect of green tea supplementation on blood pressure. Medicine  2020,99(6),e19047","journal-title":"Medicine"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/CIRCRESAHA.119.315767","volume":"126","author":"Dikalova A.E.","year":"2020","unstructured":"Dikalova A.E.; Pandey A.; Xiao L.; Arslanbaeva L.; Sidorova T.; Lopez M.G.; Billings F.T.; Verdin E.; Auwerx J.; Harrison D.G.; Dikalov S.I.; Mitochondrial deacetylase sirt3 reduces vascular dysfunction and hypertension while sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress. Circ Res  2020,126(4),439-452","journal-title":"Circ Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","volume":"365","author":"Kearney P.M.","year":"2005","unstructured":"Kearney P.M.; Whelton M.; Reynolds K.; Muntner P.; Whelton P.K.; He J.; Global burden of hypertension: Analysis of worldwide data. Lancet  2005,365(9455),217-223","journal-title":"Lancet"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijcard.2019.09.070","volume":"298","author":"Lu Y.","year":"2020","unstructured":"Lu Y.; Sun X.; Peng L.; Jiang W.; Li W.; Yuan H.; Cai J.; Angiotensin II-Induced vascular remodeling and hypertension involves cathepsin L\/V- MEK\/ERK mediated mechanism. Int J Cardiol  2020,298,98-106","journal-title":"Int J Cardiol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12974-018-1090-z","volume":"15","author":"Iulita M.F.","year":"2018","unstructured":"Iulita M.F.; Vallerand D.; Beauvillier M.; Haupert N.; A Ulysse C.; Gagn\u00e9 A.; Vernoux N.; Duchemin S.; Boily M.; Tremblay M.\u00c8.; Girouard H.; Differential effect of angiotensin II and blood pressure on hippocampal inflammation in mice. J Neuroinflammation  2018,15(1),62","journal-title":"J Neuroinflammation"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1093\/eurheartj\/ehz646","volume":"40","author":"Czesnikiewicz-Guzik M.","year":"2019","unstructured":"Czesnikiewicz-Guzik M.; Osmenda G.; Siedlinski M.; Nosalski R.; Pelka P.; Nowakowski D.; Wilk G.; Mikolajczyk T.P.; Schramm-Luc A.; Furtak A.; Matusik P.; Koziol J.; Drozdz M.; Munoz-Aguilera E.; Tomaszewski M.; Evangelou E.; Caulfield M.; Grodzicki T.; D\u2019Aiuto F.; Guzik T.J.; Causal association between periodontitis and hypertension: Evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapy. Eur Heart J  2019,40(42),3459-3470","journal-title":"Eur Heart J"},{"key":"ref=100","first-page":"158","volume":"49","author":"Agita A.","year":"2017","unstructured":"Agita A.; Alsagaff M.T.; Inflammation, immunity, and hypertension. Acta Med Indones  2017,49(2),158-165","journal-title":"Acta Med Indones"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9364364","volume":"2018","author":"Tanaka M.","year":"2018","unstructured":"Tanaka M.; Kishimoto Y.; Sasaki M.; Sato A.; Kamiya T.; Kondo K.; Iida K.; Terminalia bellirica (Gaertn.) roxb. extract and gallic acid attenuate lps-induced inflammation and oxidative stress via MAPK\/NF- \u03ba B and Akt\/AMPK\/Nrf2 Pathways. Oxid Med Cell Longev  2018,2018,1-15","journal-title":"Oxid Med Cell Longev"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"580593","DOI":"10.3389\/fimmu.2020.580593","volume":"11","author":"Lin Y.","year":"2020","unstructured":"Lin Y.; Luo T.; Weng A.; Huang X.; Yao Y.; Fu Z.; Li Y.; Liu A.; Li X.; Chen D.; Pan H.; Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling. Front Immunol  2020,11,580593","journal-title":"Front Immunol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/jcmm.13419","volume":"22","author":"Jin L.","year":"2018","unstructured":"Jin L.; Piao Z.H.; Liu C.P.; Sun S.; Liu B.; Kim G.R.; Choi S.Y.; Ryu Y.; Kee H.J.; Jeong M.H.; Gallic acid attenuates calcium calmodulin-dependent kinase II-induced apoptosis in spontaneously hypertensive rats. J Cell Mol Med  2018,22(3),1517-1526","journal-title":"J Cell Mol Med"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.12659\/MSM.908247","volume":"24","author":"Cao B.","year":"2018","unstructured":"Cao B.; Wang H.; Zhang C.; Xia M.; Yang X.; Remote ischemic postconditioning (RIPC) of the upper arm results in protection from cardiac ischemia-reperfusion injury following primary percutaneous coronary intervention (PCI) for acute ST-Segment Elevation myocardial infarction (STEMI). Med Sci Monit  2018,24,1017-1026","journal-title":"Med Sci Monit"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"569150","DOI":"10.3389\/fcell.2020.569150","volume":"8","author":"Lai T.C.","year":"2020","unstructured":"Lai T.C.; Lee T.L.; Chang Y.C.; Chen Y.C.; Lin S.R.; Lin S.W.; Pu C.M.; Tsai J.S.; Chen Y.L.; MicroRNA-221\/222 mediates adsc-exosome-induced cardioprotection against ischemia\/reperfusion by targeting PUMA and ETS-1. Front Cell Dev Biol  2020,8,569150","journal-title":"Front Cell Dev Biol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"e12413","DOI":"10.1111\/jpi.12413","volume":"63","author":"Zhou H.","year":"2017","unstructured":"Zhou H.; Zhang Y.; Hu S.; Shi C.; Zhu P.; Ma Q.; Jin Q.; Cao F.; Tian F.; Chen Y.; Melatonin protects cardiac microvasculature against ischemia\/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis. J Pineal Res  2017,63(1),e12413","journal-title":"J Pineal Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3159801","volume":"2018","author":"Zhang B.","year":"2018","unstructured":"Zhang B.; Zhai M.; Li B.; Liu Z.; Li K.; Jiang L.; Zhang M.; Yi W.; Yang J.; Yi D.; Liang H.; Jin Z.; Duan W.; Yu S.; Honokiol ameliorates myocardial ischemia\/reperfusion injury in type 1 diabetic rats by reducing oxidative stress and apoptosis through activating the SIRT1-Nrf2 signaling pathway. Oxid Med Cell Longev  2018,2018,1-16","journal-title":"Oxid Med Cell Longev"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/ijms21010358","volume":"21","author":"Kura B.","year":"2020","unstructured":"Kura B.; Szeiffova Bacova B.; Kalocayova B.; Sykora M.; Slezak J.; Oxidative stress-responsive MicroRNAs in heart injury. Int J Mol Sci  2020,21(1),358","journal-title":"Int J Mol Sci"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"827","DOI":"10.12659\/MSM.908550","volume":"24","author":"Wei G.","year":"2018","unstructured":"Wei G.; Wu Y.; Gao Q.; Shen C.; Chen Z.; Wang K.; Yu J.; Li X.; Sun X.; Gallic acid attenuates postoperative intra-abdominal adhesion by inhibiting inflammatory reaction in a rat model. Med Sci Monit  2018,24,827-838","journal-title":"Med Sci Monit"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"e17186","DOI":"10.17795\/jjnpp-17186","volume":"9","author":"Dianat M.","year":"2014","unstructured":"Dianat M.; Sadeghi N.; Badavi M.; Panahi M.; Taheri Moghadam M.; Protective effects of co-administration of gallic Acid and cyclosporine on rat myocardial morphology against ischemia\/reperfusion. Jundishapur J Nat Pharm Prod  2014,9(4),e17186","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"ref=111","unstructured":"Samarghandian, S.; Asadi-Samani, M.; Farkhondeh, T.; Bahmani, M. Assessment the effect of saffron ethanolic extract (Crocus sativus L.) on oxidative damages in aged male rat liver. Der. Pharm. Lett.  2016; 8(3):283-90."},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1248\/bpb.b18-00369","volume":"42","author":"Takahashi M.","year":"2019","unstructured":"Takahashi M.; Role of NLRP3 inflammasome in cardiac inflammation and remodeling after myocardial infarction. Biol Pharm Bull  2019,42(4),518-523","journal-title":"Biol Pharm Bull"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"707102","DOI":"10.3389\/fcvm.2021.707102","volume":"8","author":"Yu B.","year":"2021","unstructured":"Yu B.; Akushevich I.; Yashkin A.P.; Kravchenko J.; Epidemiology of geographic disparities of myocardial infarction among older adults in the united states: Analysis of 2000\u20132017 medicare data. Front Cardiovasc Med  2021,8,707102","journal-title":"Front Cardiovasc Med"},{"key":"ref=114","doi-asserted-by":"publisher","unstructured":"Farkhondeh T, Samarghandian S, Azimin-Nezhad M, Samini F. Effect of chrysin on nociception in formalin test and serum levels of noradrenalin and corticosterone in rats. Int. J. Clin. Exp. Med., 2015, 8(2), 2465.","DOI":"10.1016\/j.gheart.2018.08.004"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2017.11.024","volume":"71","author":"Thackeray J.T.","year":"2018","unstructured":"Thackeray J.T.; Hupe H.C.; Wang Y.; Bankstahl J.P.; Berding G.; Ross T.L.; Bauersachs J.; Wollert K.C.; Bengel F.M.; Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction. J Am Coll Cardiol  2018,71(3),263-275","journal-title":"J Am Coll Cardiol"},{"key":"ref=116","author":"Basit H.","year":"2022","unstructured":"Basit H.; Huecker M.R.;  Myocardial Infarction Serum Markers  2022","journal-title":"Myocardial Infarction Serum Markers"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"68","DOI":"10.14744\/AnatolJCardiol.2017.7403","volume":"18","author":"Khan H.A.","year":"2017","unstructured":"Khan H.A.; Ekhzaimy A.; Khan I.; Sakharkar M.K.; Potential of lipoproteins as biomarkers in acute myocardial infarction. Anatol J Cardiol  2017,18(1),68-74","journal-title":"Anatol J Cardiol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.12688\/f1000research.15096.1","volume":"7","author":"Saleh M.","year":"2018","unstructured":"Saleh M.; Ambrose J.A.; Understanding myocardial infarction. F1000 Res  2018,7,1378","journal-title":"F1000 Res"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12872-017-0482-9","volume":"17","author":"Johansson S.","year":"2017","unstructured":"Johansson S.; Rosengren A.; Young K.; Jennings E.; Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: A systematic review. BMC Cardiovasc Disord  2017,17(1),53","journal-title":"BMC Cardiovasc Disord"},{"key":"ref=120","first-page":"532","volume":"22","author":"Zhang Q.","year":"2018","unstructured":"Zhang Q.; Yu N.; Yu B.T.; MicroRNA-298 regulates apoptosis of cardiomyocytes after myocardial infarction. Eur Rev Med Pharmacol Sci  2018,22(2),532-539","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"e008024","DOI":"10.1161\/JAHA.117.008024","volume":"7","author":"Wang X.","year":"2018","unstructured":"Wang X.; Guo Z.; Ding Z.; Mehta J.L.; Inflammation, autophagy, and apoptosis after myocardial infarction. J Am Heart Assoc  2018,7(9),e008024","journal-title":"J Am Heart Assoc"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"165911","DOI":"10.1016\/j.bbadis.2020.165911","volume":"1866","author":"Dehghani M.A.","year":"2020","unstructured":"Dehghani M.A.; Shakiba Maram N.; Moghimipour E.; Khorsandi L.; Atefi khah M.; Mahdavinia M.; Protective effect of gallic acid and gallic acid-loaded Eudragit-RS 100 nanoparticles on cisplatin-induced mitochondrial dysfunction and inflammation in rat kidney. Biochim Biophys Acta Mol Basis Dis  2020,1866(12),165911","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"629","DOI":"10.5713\/ajas.18.0317","volume":"32","author":"Li W.","year":"2019","unstructured":"Li W.; Yue X.; Li F.; Gallic acid caused cultured mice TM4 Sertoli cells apoptosis and necrosis. Asian-Australas J Anim Sci  2019,32(5),629-636","journal-title":"Asian-Australas J Anim Sci"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/01.CIR.65.7.1446","volume":"65","author":"Hochman J.S.","year":"1982","unstructured":"Hochman J.S.; Bulkley B.H.; Expansion of acute myocardial infarction: An experimental study. Circulation  1982,65(7),1446-1450","journal-title":"Circulation"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","volume":"35","author":"Cohn J.N.","year":"2000","unstructured":"Cohn J.N.; Ferrari R.; Sharpe N.; Cardiac remodeling\u2014 concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol  2000,35(3),569-582","journal-title":"J Am Coll Cardiol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2174\/1389201022666210212125003","volume":"23","author":"Zivarpour P.","year":"2022","unstructured":"Zivarpour P.; Reiner \u017d.; Hallajzadeh J.; Mirsafaei L.; Resveratrol and cardiac fibrosis prevention and treatment. Curr Pharm Biotechnol  2022,23(2),190-200","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.7150\/ijbs.47180","volume":"16","author":"Yang D.","year":"2020","unstructured":"Yang D.; Liu H.Q.; Liu F.Y.; Tang N.; Guo Z.; Ma S.Q.; An P.; Wang M.Y.; Wu H.M.; Yang Z.; Fan D.; Tang Q.Z.; The roles of noncardiomyocytes in cardiac remodeling. Int J Biol Sci  2020,16(13),2414-2429","journal-title":"Int J Biol Sci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5935\/abc.20160005","volume":"106","author":"Azevedo P.S.","year":"2016","unstructured":"Azevedo P.S.; Polegato B.F.; Minicucci M.F.; Paiva S.A.R.; Zornoff L.A.M.; Cardiac remodeling: Concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol  2016,106(1),62-69","journal-title":"Arq Bras Cardiol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"3920195","DOI":"10.1155\/2017\/3920195","volume":"2017","author":"Schirone L.","year":"2017","unstructured":"Schirone L.; A review of the molecular mechanisms underlying the development and progression of cardiac remodeling. Oxid Med Cell Longev  2017,2017,3920195","journal-title":"Oxid Med Cell Longev"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"S452","DOI":"10.1054\/jcaf.2002.129286","volume":"8","author":"Anand I.S.","year":"2002","unstructured":"Anand I.S.; Florea V.G.; Solomon S.D.; Konstam M.A.; Udelson J.E.; Noninvasive assessment of left ventricular remodeling: Concepts, techniques, and implications for clinical trials. J Card Fail  2002,8(6)(Suppl.),S452-S464","journal-title":"J Card Fail"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/cvr\/cvx073","volume":"113","author":"Poncelas M.","year":"2017","unstructured":"Poncelas M.; Inserte J.; Aluja D.; Hernando V.; Vilardosa U.; Garcia-Dorado D.; Delayed, oral pharmacological inhibition of calpains attenuates adverse post-infarction remodelling. Cardiovasc Res  2017,113(8),950-961","journal-title":"Cardiovasc Res"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ejhf.62","volume":"16","author":"Tarone G.","year":"2014","unstructured":"Tarone G.; Balligand J.L.; Bauersachs J.; Clerk A.; De Windt L.; Heymans S.; Hilfiker-Kleiner D.; Hirsch E.; Iaccarino G.; Kn\u00f6ll R.; Leite-Moreira A.F.; Louren\u00e7o A.P.; Mayr M.; Thum T.; Tocchetti C.G.; Targeting myocardial remodelling to develop novel therapies for heart failure. Eur J Heart Fail  2014,16(5),494-508","journal-title":"Eur J Heart Fail"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","volume":"90","author":"Rose B.A.","year":"2010","unstructured":"Rose B.A.; Force T.; Wang Y.; Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale. Physiol Rev  2010,90(4),1507-1546","journal-title":"Physiol Rev"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"34790","DOI":"10.1038\/srep34790","volume":"6","author":"Ryu Y.","year":"2016","unstructured":"Ryu Y.; Jin L.; Kee H.J.; Piao Z.H.; Cho J.Y.; Kim G.R.; Choi S.Y.; Lin M.Q.; Jeong M.H.; Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. Sci Rep  2016,6(1),34790","journal-title":"Sci Rep"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"30245","DOI":"10.1074\/jbc.M102174200","volume":"276","author":"Liang Q.","year":"2001","unstructured":"Liang Q.; De Windt L.J.; Witt S.A.; Kimball T.R.; Markham B.E.; Molkentin J.D.; The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem  2001,276(32),30245-30253","journal-title":"J Biol Chem"},{"key":"ref=136","doi-asserted-by":"publisher","DOI":"10.1177\/09603271211064532","volume":"41","author":"Shackebaei D.","year":"2022","unstructured":"Shackebaei D.; Hesari M.; Ramezani-Aliakbari S.; Hoseinkhani Z.; Ramezani-Aliakbari F.; Gallic acid protects against isoproterenol-induced cardiotoxicity in rats. Hum Exp Toxicol  2022,41","journal-title":"Hum Exp Toxicol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","volume":"19","author":"Segura A.M.","year":"2014","unstructured":"Segura A.M.; Frazier O.H.; Buja L.M.; Fibrosis and heart failure. Heart Fail Rev  2014,19(2),173-185","journal-title":"Heart Fail Rev"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"Kong P.","year":"2014","unstructured":"Kong P.; Christia P.; Frangogiannis N.G.; The pathogenesis of cardiac fibrosis. Cell Mol Life Sci  2014,71(4),549-574","journal-title":"Cell Mol Life Sci"},{"key":"ref=139","first-page":"1789","volume":"60","author":"Arola O.J.","year":"2000","unstructured":"Arola O.J.; Saraste A.; Pulkki K.; Kallajoki M.; Parvinen M.; Voipio-Pulkki L.M.; Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res  2000,60(7),1789-1792","journal-title":"Cancer Res"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bbadis.2009.06.004","volume":"1792","author":"Pohlers D.","year":"2009","unstructured":"Pohlers D.; Brenmoehl J.; L\u00f6ffler I.; M\u00fcller C.K.; Leipner C.; Schultze-Mosgau S.; Stallmach A.; Kinne R.W.; Wolf G.; TGF-\u03b2 and fibrosis in different organs : Molecular pathway imprints. Biochim Biophys Acta Mol Basis Dis  2009,1792(8),746-756","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1097\/HJH.0000000000001327","volume":"35","author":"Jin L.","year":"2017","unstructured":"Jin L.; Lin M.Q.; Piao Z.H.; Cho J.Y.; Kim G.R.; Choi S.Y.; Ryu Y.; Sun S.; Kee H.J.; Jeong M.H.; Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with N G-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2. J Hypertens  2017,35(7),1502-1512","journal-title":"J Hypertens"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI74783","volume":"124","author":"Moore-Morris T.","year":"2014","unstructured":"Moore-Morris T.; Guimar\u00e3es-Camboa N.; Banerjee I.; Zambon A.C.; Kisseleva T.; Velayoudon A.; Stallcup W.B.; Gu Y.; Dalton N.D.; Cedenilla M.; Gomez-Amaro R.; Zhou B.; Brenner D.A.; Peterson K.L.; Chen J.; Evans S.M.; Resident fibroblast lineages mediate pressure overload\u2013induced cardiac fibrosis. J Clin Invest  2014,124(7),2921-2934","journal-title":"J Clin Invest"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"9302","DOI":"10.1038\/s41598-018-27599-4","volume":"8","author":"Jin L.","year":"2018","unstructured":"Jin L.; Sun S.; Ryu Y.; Piao Z.H.; Liu B.; Choi S.Y.; Kim G.R.; Kim H.S.; Kee H.J.; Jeong M.H.; Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure. Sci Rep  2018,8(1),9302","journal-title":"Sci Rep"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/ctrv.2000.0175","volume":"26","author":"Meinardi M.T.","year":"2000","unstructured":"Meinardi M.T.; Gietema J.A.; van Veldhuisen D.J.; van der Graaf W.T.A.; de Vries E.G.E.; Sleijfer D.T.; Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat Rev  2000,26(6),429-447","journal-title":"Cancer Treat Rev"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.phymed.2004.09.003","volume":"13","author":"Mohan I.K.","year":"2006","unstructured":"Mohan I.K.; Kumar K.V.; Naidu M.U.R.; Khan M.; Sundaram C.; Protective effect of CardiPro against doxorubicin-induced cardiotoxicity in mice. Phytomedicine  2006,13(4),222-229","journal-title":"Phytomedicine"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Octavia Y.","year":"2012","unstructured":"Octavia Y.; Tocchetti C.G.; Gabrielson K.L.; Janssens S.; Crijns H.J.; Moens A.L.; Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol  2012,52(6),1213-1225","journal-title":"J Mol Cell Cardiol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/2349-5006.158219","volume":"8","author":"Swamy A.H.M.V.","year":"2015","unstructured":"Swamy A.H.M.V.; Kulkarni J.M.; Cardioprotective effect of gallic acid against doxorubicin-induced myocardial toxicity in albino rats. Ind J Heal Sci Biomed Res  2015,8(1),28","journal-title":"Ind J Heal Sci Biomed Res"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5731372","volume":"2022","author":"Han S.","year":"2022","unstructured":"Han S.; Bao L.; Li W.; Liu K.; Tang Y.; Han X.; Liu Z.; Wang H.; Zhang F.; Mi S.; Du H.; Gallic acid inhibits mesaconitine-activated TRPV1-channel-induced cardiotoxicity. Evid Based Complement Alternat Med  2022,2022,1-12","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"S530","DOI":"10.1177\/09603271211053299","volume":"40","author":"Salimi A.","year":"2021","unstructured":"Salimi A.; Atashbar S.; Shabani M.; Gallic acid inhibits celecoxib-induced mitochondrial permeability transition and reduces its toxicity in isolated cardiomyocytes and mitochondria. Hum Exp Toxicol  2021,40(12_suppl)(Suppl.),S530-S539","journal-title":"Hum Exp Toxicol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/13813455.2019.1630652","volume":"127","author":"Ekinci Akdemir F.N.","year":"2021","unstructured":"Ekinci Akdemir F.N.; Yildirim S.; Kandemir F.M.; Tanyeli A.; K\u00fc\u00e7\u00fckler S.; Bahaeddin Dortbudak M.; Protective effects of gallic acid on doxorubicin-induced cardiotoxicity; An experimantal study. Arch Physiol Biochem  2021,127(3),258-265","journal-title":"Arch Physiol Biochem"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.vph.2017.10.007","volume":"99","author":"Jin L.","year":"2017","unstructured":"Jin L.; Piao Z.H.; Sun S.; Liu B.; Ryu Y.; Choi S.Y.; Kim G.R.; Kim H.S.; Kee H.J.; Jeong M.H.; Gallic acid attenuates pulmonary fibrosis in a mouse model of transverse aortic contraction-induced heart failure. Vascul Pharmacol  2017,99,74-82","journal-title":"Vascul Pharmacol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"594683","DOI":"10.3389\/fcell.2020.594683","volume":"8","author":"Han D.","year":"2020","unstructured":"Han D.; Zhang Q.Y.; Zhang Y.L.; Han X.; Guo S.B.; Teng F.; Yan X.; Li H.H.; Gallic acid ameliorates angiotensin II-induced atrial fibrillation by inhibiting immunoproteasome-mediated PTEN degradation in mice. Front Cell Dev Biol  2020,8,594683","journal-title":"Front Cell Dev Biol"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"109132","DOI":"10.1016\/j.jnutbio.2022.109132","volume":"110","author":"Clark M.","year":"2022","unstructured":"Clark M.; Centner A.M.; Ukhanov V.; Nagpal R.; Salazar G.; Gallic acid ameliorates atherosclerosis and vascular senescence and remodels the microbiome in a sex-dependent manner in ApoE mice. J Nutr Biochem  2022,110,109132","journal-title":"J Nutr Biochem"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.biopha.2017.10.014","volume":"96","author":"Ramezani-Aliakbari F.","year":"2017","unstructured":"Ramezani-Aliakbari F.; Badavi M.; Dianat M.; Mard S.A.; Ahangarpour A.; Effects of gallic acid on hemodynamic parameters and infarct size after ischemia-reperfusion in isolated rat hearts with alloxan-induced diabetes. Biomed Pharmacother  2017,96,612-618","journal-title":"Biomed Pharmacother"},{"key":"ref=155","first-page":"515","volume":"22","author":"Ramezani-Aliakbari F.","year":"2019","unstructured":"Ramezani-Aliakbari F.; Badavi M.; Dianat M.; Mard S.A.; Ahangarpour A.; Protective effects of gallic acid on cardiac electrophysiology and arrhythmias during reperfusion in diabetes. Iran J Basic Med Sci  2019,22(5),515-520","journal-title":"Iran J Basic Med Sci"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673259299230921150030","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/221747\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673259299230921150030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T07:14:20Z","timestamp":1720163660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/221747\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":155,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673259299230921150030","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}